Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0001104659-26-080009 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
7,149,461
Total Value
$300,014,406.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 1, 2026 | Conversion | 3,553,410 | โ | โ | 4,685,364 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 3,553,410 | $84.43 | $300,014,406.30 | 1,131,954 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details | |
Director | Series B Preferred Stock | Derivative | Jul 1, 2026 | Conversion | 42,641 | $0.00 | $0.00 | 94,497 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details |